| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial
|
Ichiki, Masao
|
|
2005
|
58 |
3 |
p. 368-373
|
artikel
|
| 2 |
Biliary excretion of etoposide in children with cancer
|
Veal, Gareth J.
|
|
2005
|
58 |
3 |
p. 415-417
|
artikel
|
| 3 |
Clindamycin–paclitaxel pharmacokinetic interaction in ovarian cancer patients
|
Fruscio, Robert
|
|
2005
|
58 |
3 |
p. 319-325
|
artikel
|
| 4 |
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan
|
Gupta, Anshul
|
|
2005
|
58 |
3 |
p. 374-383
|
artikel
|
| 5 |
Dihydropyrimidine dehydrogenase deficiency in an Indian population
|
Saif, Muhammad Wasif
|
|
2006
|
58 |
3 |
p. 396-401
|
artikel
|
| 6 |
Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents
|
Liu, Y.-L.
|
|
2006
|
58 |
3 |
p. 326-333
|
artikel
|
| 7 |
Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells
|
Cheng, Timothy C.
|
|
2005
|
58 |
3 |
p. 384-395
|
artikel
|
| 8 |
Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1)
|
Matsunaga, Seita
|
|
2005
|
58 |
3 |
p. 348-353
|
artikel
|
| 9 |
Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy
|
Liu, Jubo
|
|
2005
|
58 |
3 |
p. 306-318
|
artikel
|
| 10 |
Pharmacodynamic properties of methotrexate and AminotrexateTM during weekly therapy
|
Cole, Peter D.
|
|
2006
|
58 |
3 |
p. 418
|
artikel
|
| 11 |
Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen
|
Poujol, Sylvain
|
|
2005
|
58 |
3 |
p. 292-305
|
artikel
|
| 12 |
Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer
|
Yamamoto, Nobuyuki
|
|
2006
|
58 |
3 |
p. 285-291
|
artikel
|
| 13 |
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group
|
Warren, K.
|
|
2006
|
58 |
3 |
p. 343-347
|
artikel
|
| 14 |
Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers
|
Harisi, Revekka
|
|
2005
|
58 |
3 |
p. 334-342
|
artikel
|
| 15 |
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy
|
Shinohara, Nobuo
|
|
2005
|
58 |
3 |
p. 402-407
|
artikel
|
| 16 |
The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin
|
Damber, Jan-Erik
|
|
2005
|
58 |
3 |
p. 354-360
|
artikel
|
| 17 |
The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer
|
Hirose, Takashi
|
|
2005
|
58 |
3 |
p. 361-367
|
artikel
|
| 18 |
The cytotoxic and genotoxic potential of 5-aminolevulinic acid on lymphocytes: a comet assay study
|
Chu, E. S. M.
|
|
2006
|
58 |
3 |
p. 408-414
|
artikel
|
Tijdschrift beschrijving